Abstract

BackgroundTumor-infiltrating lymphocytes (TILs) serve as both prognostic and predictive biomarker in triple-negative breast cancer (TNBC). TNBC exhibits six distinct molecular subtypes —basal-like 1, basal-like 2, mesenchymal, mesenchymal stem-like, immunomodulatory (IM),...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call